Skip to main content
PepStack
Blutwerte · Marker

Resistin

Resistin · FIZZ3

Adipokine & Metabolische HormoneNüchtern erforderlichZeitabhängig
Einheit:
ng/mL

Resistin quantifies the level of a secretory protein involved in inflammation and metabolic regulation.

Reference Ranges

Reference
722ng/mL
7
22
LowNormalHigh
Reference
Unit · ng/mL

Reference ranges may vary based on sex, age, and fasting status.

Overview

Übersicht

Resistin is a small secretory protein categorized as an adipokine and metabolic hormone. It is primarily involved in the regulation of inflammation and metabolic processes. In humans, resistin is secreted by immune cells and is associated with inflammatory responses, while in rodents, it is secreted by adipocytes and linked to insulin resistance. Clinically, resistin is significant as it is associated with obesity, type 2 diabetes, and cardiovascular diseases. Elevated levels of resistin have been observed in conditions characterized by chronic inflammation, such as obesity and metabolic syndrome, and may serve as a biomarker for these conditions. Researchers have found that resistin is involved in the pathophysiology of these diseases by promoting inflammatory pathways and contributing to insulin resistance. In the context of athletic performance, biohacking, or longevity, resistin's role in inflammation and metabolism may influence recovery and adaptation to physical stress. However, its direct impact on athletic performance or longevity is less clear and requires further investigation. Caveats in measuring resistin include potential confounding factors such as obesity, inflammatory status, and circadian rhythms. Time-of-day and fasting status may influence resistin levels, and researchers recommend standardizing these conditions during testing to ensure accurate and comparable results.

Klinische Bedeutung

Elevated resistin levels indicate increased inflammation and are associated with obesity, type 2 diabetes, and cardiovascular diseases. Low resistin levels are less commonly discussed but may indicate reduced inflammatory activity.

Dynamics

Trend Interpretation

Rising Values

Progressively rising resistin levels suggest worsening inflammation or metabolic dysfunction. Retesting in 3-6 months is recommended.

Falling Values

Progressively falling resistin levels may indicate improved inflammation or metabolic health.

Re-test Interval

6 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Obesity
  • Chronic inflammation
  • Type 2 diabetes
  • Cardiovascular disease
  • Metabolic syndrome
Cause

Low Levels

  • Reduced inflammatory activity
  • Weight loss
  • Improved metabolic health
  • Anti-inflammatory interventions
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Weight management
  • Stress reduction
Lever

Nutrition

  • Anti-inflammatory diet
  • High-fiber foods
  • Omega-3 fatty acids
Lever

Supplementation

  • Omega-3 supplements
  • Curcumin
  • Resveratrol

Note:

Consult a healthcare provider before starting any supplementation, especially if you have underlying health conditions.

Testing Guidelines

🍽️Fasting Required
🕐Time-Sensitive

Resistin levels may vary throughout the day; morning measurements are recommended.

Testing Frequency

Annually for individuals with metabolic syndrome or obesity.

Interfering Factors

  • Recent intense exercise
  • Acute infections
  • Chronic inflammatory conditions

Related Peptides & Hormones

Leptin

Correlated with

hormone

Open Research Questions

Current research suggests that reference ranges and optimal targets for resistin levels remain poorly defined, particularly in diverse populations and clinical contexts. Researchers have not yet established the confounding effects of factors such as circadian misalignment and obesity on resistin's role as a biomarker. Additionally, unanswered clinical questions include the precise mechanisms by which resistin influences inflammation and metabolic disorders, as well as its potential as a therapeutic target in obesity-related diseases.

18 Research Publications

3,033

Total Citations

5

Human/RCT

8.8

Avg. Influence

2021

Latest

Sort
Filter
#01

Obesity and cancer risk: Emerging biological mechanisms and perspectives.

ReviewInfluence34.0
1219
This study examined the relationship between obesity and cancer risk, finding that excess body weight is linked to an increased risk of at least 13 types of cancer. Researchers highlighted emerging biological mechanisms, including insulin resistance and chronic inflammation, that connect obesity to cancer development.
View on PubMed
#02

Circadian misalignment increases cardiovascular disease risk factors in humans.

HumanInfluence13.0
577
Researchers found that short-term circadian misalignment significantly increases cardiovascular disease risk factors, including elevated blood pressure and inflammatory markers like resistin. The study demonstrated that these changes occur during both sleep and wake periods.
View on PubMed
#03

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.

ReviewInfluence13.0
423
Researchers aimed to identify potential frailty biomarkers related to aging, highlighting resistin among others. The study proposed a core panel of biomarkers that could help assess frailty and related health risks in older adults.
View on PubMed
#04

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation.

ReviewInfluence5.0
204
This review focused on the role of adipokines, including resistin, in chronic low-grade inflammation in adipose tissue, which is linked to obesity and metabolic disorders. Researchers discussed how these proteins influence inflammation and metabolic abnormalities.
View on PubMed
#05

Resistin in metabolism, inflammation, and disease.

Tripathi Deeksha, et al. · The FEBS journal · 2020

ReviewInfluence5.0
182
This study summarized the diverse roles of resistin in metabolism and inflammation, noting its association with obesity and stress response mechanisms. Researchers emphasized its potential as a biomarker for disease diagnostics.

Key findings

  1. 01Resistin has different functions in mice and humans, affecting metabolism and inflammation.
  2. 02In mice, resistin is associated with insulin resistance and type 2 diabetes.
  3. 03In humans, resistin is linked to inflammation and may serve as a biomarker for disease evaluation.
View on PubMed
#06

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

ReviewInfluence2.0
153
This study reviewed the interactions between adipokines, myokines, and hepatokines, including resistin, in metabolic disorders. Researchers found that these biomarkers can have both harmful and beneficial effects on health outcomes.
View on PubMed
#07

Adipokines: Biomarkers for osteoarthritis?

ReviewInfluence9.0
110
Researchers reviewed the role of adipokines, including resistin, in osteoarthritis (OA), suggesting that these molecules may serve as biomarkers for disease diagnosis and monitoring. The study highlighted altered levels of resistin in OA patients.
View on PubMed
#08

Resistin: Potential biomarker and therapeutic target in atherosclerosis.

Zhou Li, et al. · Clinica chimica acta; international journal of clinical chemistry · 2021

ReviewInfluence3.0
60
This study highlighted resistin's role in atherosclerosis, noting its involvement in vascular inflammation and plaque vulnerability. Researchers suggested that resistin could serve as a therapeutic or diagnostic target for cardiovascular diseases.

Key findings

  1. 01Resistin can trigger inflammation and lipid accumulation in blood vessels.
  2. 02It affects various cell types, contributing to cardiovascular problems like atherosclerosis.
  3. 03The study highlights resistin as a potential target for future cardiovascular disease therapies and diagnostics.
View on PubMed
#09

Resistin and cardiovascular disease.

Ding Qinxue, et al. · Trends in cardiovascular medicine · 2011

ReviewInfluence3.0
40
This review examined the association of resistin with cardiovascular diseases, including coronary artery disease and heart failure. Researchers noted its potential as a diagnostic and prognostic marker, although further studies are needed to clarify its role.

Key findings

  1. 01Resistin is associated with coronary and peripheral artery diseases, including ischemic stroke.
  2. 02Its role as a diagnostic and prognostic marker for cardiovascular disease is complicated by other inflammatory markers.
  3. 03Further large-scale studies are necessary to better understand resistin's function in heart disease.
View on PubMed
#10

Obesity-Related Biomarkers Are Associated With Exercise Intolerance and HFpEF.

HumanInfluence1.0
30
Researchers investigated the relationship between obesity-related biomarkers, including resistin, and heart failure with preserved ejection fraction (HFpEF). The study found that higher levels of certain biomarkers were associated with impaired exercise capacity and HFpEF status.
View on PubMed

Publication Trend

Research publications about Resistin over time

10total
1
'11
1
'14
1
'16
1
'18
1
'19
2
'20
1
'22
1
'23
1
'26

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer